Efalizumab.
Marecki
Sylvia
S
Kirkpatrick
Peter
P
D000911:Antibodies, Monoclonal / Q000191:economics / Q000378:metabolism / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002986:Clinical Trials as Topic; D015507:Drugs, Investigational / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy* / Q000191:economics
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D015507:Drugs, Investigational; C472181:efalizumab